HM Payson & Co’s Eli Lilly LLY Stock Holding History

HM Payson & Co’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$64.3M	Sell	53,616 -2,419	-4%	-$2.47M	0.85%	31
2026 Q1	$51.5M	Buy	56,035 +9,647	+21%	+$9.78M	0.74%	41
2025 Q4	$49.9M	Buy	46,388 +6,356	+16%	+$6.08M	0.7%	38
2025 Q3	$30.5M	Sell	40,032 -100	-0.2%	-$74.4K	0.44%	52
2025 Q2	$31.3M	Buy	40,132 +18,792	+88%	+$14.6M	0.5%	48
2025 Q1	$17.6M	Sell	21,340 -207	-1%	-$172K	0.31%	63
2024 Q4	$16.6M	Sell	21,547 -406	-2%	-$336K	0.28%	66
2024 Q3	$19.4M	Buy	21,953 +378	+2%	+$340K	0.33%	65
2024 Q2	$19.5M	Sell	21,575 -2,002	-8%	-$1.6M	0.35%	57
2024 Q1	$18.3M	Sell	23,577 -823	-3%	-$586K	0.34%	63
2023 Q4	$14.2M	Sell	24,400 -1,132	-4%	-$661K	0.29%	67
2023 Q3	$13.7M	Buy	25,532 +1,075	+4%	+$554K	0.32%	61
2023 Q2	$11.5M	Buy	24,457 +3,146	+15%	+$1.32M	0.26%	69
2023 Q1	$7.32M	Buy	21,311 +1,420	+7%	+$479K	0.18%	76
2022 Q4	$7.28M	Sell	19,891 -2,016	-9%	-$715K	0.18%	74
2022 Q3	$7.08M	Buy	21,907 +299	+1%	+$94.7K	0.19%	78
2022 Q2	$7.01M	Sell	21,608 -61	-0.3%	-$18.3K	0.18%	84
2022 Q1	$6.21M	Buy	21,669 +74	+0.3%	+$19K	0.14%	91
2021 Q4	$5.96M	Sell	21,595 -388	-2%	-$98.4K	0.13%	100
2021 Q3	$5.08M	Buy	21,983 +1,971	+10%	+$486K	0.12%	103
2021 Q2	$4.59M	Buy	20,012 +178	+0.9%	+$35.8K	0.11%	113
2021 Q1	$3.71M	Sell	19,834 -246	-1%	-$48.1K	0.1%	122
2020 Q4	$3.39M	Sell	20,080 -1,847	-8%	-$276K	0.09%	123
2020 Q3	$3.25M	Sell	21,927 -220	-1%	-$34K	0.1%	115
2020 Q2	$3.64M	Sell	22,147 -166	-0.7%	-$25.5K	0.12%	104
2020 Q1	$3.1M	Sell	22,313 -635	-3%	-$87.2K	0.12%	101
2019 Q4	$3.02M	Sell	22,948 -235	-1%	-$27.2K	0.1%	118
2019 Q3	$2.59M	Buy	23,183 +35	+0.2%	+$3.9K	0.09%	129
2019 Q2	$2.56M	Sell	23,148 -241	-1%	-$28.4K	0.09%	134
2019 Q1	$3.04M	Buy	+23,389	New	+$2.84M	0.12%	118
2018 Q4	–	Sell	-23,891	Closed	-$2.56M	–	251
2018 Q3	$2.56M	Sell	23,891 -592	-2%	-$59.2K	0.11%	123
2018 Q2	$2.09M	Sell	24,483 -1,151	-4%	-$94.5K	0.09%	132
2018 Q1	$1.98M	Buy	25,634 +37	+0.1%	+$2.98K	0.08%	141
2017 Q4	$2.16M	Sell	25,597 -1,712	-6%	-$146K	0.09%	142
2017 Q3	$2.34M	Sell	27,309 -692	-2%	-$56.8K	0.1%	138
2017 Q2	$2.31M	Sell	28,001 -175	-0.6%	-$14.3K	0.1%	132
2017 Q1	$2.37M	Sell	28,176 -400	-1%	-$32K	0.11%	132
2016 Q4	$2.1M	Sell	28,576 -1,000	-3%	-$74.5K	0.1%	134
2016 Q3	$2.37M	Hold	29,576	–	–	0.12%	130
2016 Q2	$2.33M	Sell	29,576 -1,546	-5%	-$116K	0.12%	123
2016 Q1	$2.24M	Buy	31,122 +485	+2%	+$36.7K	0.12%	124
2015 Q4	$2.58M	Buy	30,637 +202	+0.7%	+$16.8K	0.13%	124
2015 Q3	$2.55M	Sell	30,435 -5,157	-14%	-$435K	0.14%	120
2015 Q2	$2.97M	Buy	35,592 +570	+2%	+$43.4K	0.15%	121
2015 Q1	$2.54M	Sell	35,022 -22	-0.1%	-$1.57K	0.13%	123
2014 Q4	$2.42M	Hold	35,044	–	–	0.12%	127
2014 Q3	$2.27M	Buy	35,044 +2,006	+6%	+$127K	0.12%	126
2014 Q2	$2.05M	Buy	33,038 +1,114	+3%	+$66.5K	0.11%	131
2014 Q1	$1.88M	Sell	31,924 -300	-0.9%	-$16.7K	0.1%	136
2013 Q4	$1.64M	Hold	32,224	–	–	0.09%	139
2013 Q3	$1.62M	Sell	32,224 -297	-0.9%	-$15.5K	0.09%	136
2013 Q2	$1.6M	Buy	+32,521	New	+$1.77M	0.1%	134

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

HM Payson & Co's LLY Position: Q2 2026 in Review

HM Payson & Co reduced its Eli Lilly (LLY) stake by 4.3% in Q2 2026, selling an estimated $2.47M and leaving 53,616 shares worth $64.3M. The position accounts for 0.85% of the portfolio, ranked #31.

HM Payson & Co first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

HM Payson & Co held 53,616 shares of Eli Lilly worth $64.3M as of Q2 2026.
HM Payson & Co sold 2,419 Eli Lilly shares in Q2 2026, an estimated $2.47M.
Eli Lilly made up 0.85% of HM Payson & Co's portfolio in Q2 2026, its #31 holding.
HM Payson & Co first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.